BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38511470)

  • 1. Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities.
    Wang D; Bolleddula J; Coenen-Stass A; Grombacher T; Dong JQ; Scheuenpflug J; Locatelli G; Feng Z
    Pharmacogenomics; 2024 Mar; 25(4):197-206. PubMed ID: 38511470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics.
    Pandi MT; Williams MS; van der Spek P; Koromina M; Patrinos GP
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32443490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Next-Generation Sequencing in Pharmacogenomics.
    Enko D; Michaelis S; Schneider C; Schaflinger E; Baranyi A; Schnedl WJ; Muller DJ
    Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundoscopy-directed genetic testing to re-evaluate negative whole exome sequencing results.
    Cho A; Lima de Carvalho JR; Tanaka AJ; Jauregui R; Levi SR; Bassuk AG; Mahajan VB; Tsang SH
    Orphanet J Rare Dis; 2020 Jan; 15(1):32. PubMed ID: 32000842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of genome sequencing and clinical genotyping for pharmacogenes.
    Yang W; Wu G; Broeckel U; Smith CA; Turner V; Haidar CE; Wang S; Carter R; Karol SE; Neale G; Crews KR; Yang JJ; Mullighan CG; Downing JR; Evans WE; Relling MV
    Clin Pharmacol Ther; 2016 Oct; 100(4):380-8. PubMed ID: 27311679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
    Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
    Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
    O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
    Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of somatic copy number estimation tools for whole-exome sequencing data.
    Nam JY; Kim NK; Kim SC; Joung JG; Xi R; Lee S; Park PJ; Park WY
    Brief Bioinform; 2016 Mar; 17(2):185-92. PubMed ID: 26210357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of single nucleotide variant detection performance using three massively parallel sequencing methods.
    Trudsø LC; Andersen JD; Jacobsen SB; Christiansen SL; Congost-Teixidor C; Kampmann ML; Morling N
    PLoS One; 2020; 15(9):e0239850. PubMed ID: 32986766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
    Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
    J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole exome sequencing in the rat.
    Foley JF; Phadke DP; Hardy O; Hardy S; Miller V; Madan A; Howard K; Kruse K; Lord C; Ramaiahgari S; Solomon GG; Shah RR; Pandiri AR; Herbert RA; Sills RC; Merrick BA
    BMC Genomics; 2018 Jun; 19(1):487. PubMed ID: 29925311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.
    Ghazani AA; Oliver NM; St Pierre JP; Garofalo A; Rainville IR; Hiller E; Treacy DJ; Rojas-Rudilla V; Wood S; Bair E; Parello M; Huang F; Giannakis M; Wilson FH; Stover EH; Corsello SM; Nguyen T; Rana HQ; Church AJ; Lowenstein C; Cibulskis C; Amin-Mansour A; Heng J; Brais L; Santos A; Bauer P; Waldron A; Lo P; Gorman M; Lydon CA; Welch M; McNamara P; Gabriel S; Sholl LM; Lindeman NI; Garber JE; Joffe S; Van Allen EM; Gray SW; Ja Nne PA; Garraway LA; Wagle N
    Genet Med; 2017 Jul; 19(7):787-795. PubMed ID: 28125075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.
    Silgado-Guzmán DF; Angulo-Aguado M; Morel A; Niño-Orrego MJ; Ruiz-Torres DA; Contreras Bravo NC; Restrepo CM; Ortega-Recalde O; Fonseca-Mendoza DJ
    Front Pharmacol; 2022; 13():931531. PubMed ID: 35846994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer pharmacogenetics: targeted sequencing panels or exome sequencing?
    Tilleman L; Heindryckx B; Deforce D; Van Nieuwerburgh F
    Pharmacogenomics; 2020 Oct; 21(15):1073-1084. PubMed ID: 33019866
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
    Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
    BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing.
    Ly RC; Shugg T; Ratcliff R; Osei W; Lynnes TC; Pratt VM; Schneider BP; Radovich M; Bray SM; Salisbury BA; Parikh B; Sahinalp SC; Numanagić I; Skaar TC
    J Mol Diagn; 2022 Jun; 24(6):576-585. PubMed ID: 35452844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic dissection of biases in whole-exome and whole-genome sequencing reveals major determinants of coding sequence coverage.
    Barbitoff YA; Polev DE; Glotov AS; Serebryakova EA; Shcherbakova IV; Kiselev AM; Kostareva AA; Glotov OS; Predeus AV
    Sci Rep; 2020 Feb; 10(1):2057. PubMed ID: 32029882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.